Drawing for ESTURA

USPTO serial 77483339

ESTURA

Reviewed by CopyMark Law Group

Reg. 4033042Status 710
Filing date
Status date
Registration date
Oct 4, 2011
Examiner
CARLSON, KRISTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ESTURA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John K. Park and Chong H. Roh

JOHN K. PARK AND CHONG H. ROH PARK LAW FIRM3255 WILSHIRE BLVD STE 1110LOS ANGELES, CA 90010-1415UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Food for babies; Dietetic milk sugar for medical use; Lacteal flour for use as baby food; Nutritive substances of microorganisms for medical and veterinary purposes; First aid kits; Fly catching paper; liniment; Pharmaceutical preparations for skin care; Allergy medications; Pharmaceutical skin lotions; Medicinal preparations for stimulating hair growth; Balms for medical purposes; Antibiotic ointments; Anti-inflammatory ointments; Anti-itch ointment; Hemorrhoidal ointments; Medicated diaper rash ointments and lotions; Vitamin preparations; Diet pills; Dietetic foods adapted for medical use; Meal replacement and dietary supplement drink mixes; Stimulatory medications for use in weight reduction programs; Therapeutic agents for weight control and appetite suppression; Pharmaceutical preparations, namely, appetite suppressants; Medicinal tea; Antiphlogistic; Poultices; Medicated compresses; Pharmaceutical preparations for treating dandruff; Sunburn preparations for pharmaceutical purposes; Eye patches for medical purposes; Bandages for skin wounds; Plasters for medical purposes; Analgesics; Topical analgesics; Anti-inflammatory and antipyretic preparations; Pharmaceutical preparations for use in the treatment of epidermal diseases, diseases of the central nervous system, diseases of the peripheral nervous system, allergic reactions, and tumors; Antibiotics; Antiseptics; Medical Plasters; Pharmaceuticals for the treatment of rheumatoid arthritis; Anti-inflammatory agents; Febrifuges; Adhesive bandages; Medical adhesive tape; Adjuvants for medical purposes; Anaesthetics; Antiseptic cotton; Bandages for dressings; Chemical reagents for medical purposes; Pharmaceutical preparations for the treatment of dermatosis; Chemico-pharmaceutical preparations for treatment of infectious diseases, pain, irritation, drug dependency and suppression of the symptoms of drug withdrawal, anemia, cardiovascular system diseases, and asthma relief and coughs; Preparations for cleansing the skin for medical use; Diagnostic preparations for medical purposes; Digestives for pharmaceutical purposes; Fecal enzyme inhibiting compositions used as an ingredient in medicated creams, ointments and lotions; Ferments for pharmaceutical purposes; Hematogen; Hemoglobin; Headache treatment preparations; Lozenges for pharmaceutical purposes; Nutritive substances of microorganism cultures for medical and veterinary use; Reagents for medical or veterinary purposes; Serotherapeutic medicines; Medicated serums for the treatment of wounds and skincare; Siccatives for medical purposes; Vaccines; Vermifuges; Appetite suppressants for medical purposes; Adhesive bandages; Medical adhesive tape; Medical adhesives for binding wounds; Burn relief medication; Dressings for burns; Fungicides; Germicides; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology, and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for the treatment of bacteria-based diseases; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations, namely, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 11, 2018C8..CANCELLED SEC. 8 (6-YR)—
Oct 4, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2011NPUBNOTICE OF PUBLICATION—
Jun 10, 2011ATRVATTORNEY REVIEW COMPLETED—
Jun 3, 2011ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Jun 3, 2011ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Jun 3, 201144EG44(e) PETITION - GRANTED—
May 31, 2011APETASSIGNED TO PETITION STAFF—
May 27, 2011IUCNNOTICE OF ALLOWANCE CANCELLED—
May 27, 2011TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Apr 15, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Apr 14, 2011EX3GSOU EXTENSION 3 GRANTED—
Apr 12, 2011EXT3SOU EXTENSION 3 FILED—
Apr 12, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 26, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Oct 25, 2010EX2GSOU EXTENSION 2 GRANTED—
Oct 25, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 8, 2010EXT2SOU EXTENSION 2 FILED—
Oct 8, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 13, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Apr 9, 2010EX1GSOU EXTENSION 1 GRANTED—
Apr 9, 2010EXT1SOU EXTENSION 1 FILED—
Apr 9, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 21, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2009NPUBNOTICE OF PUBLICATION—
Jun 12, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 11, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 23, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 10, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2009ALIEASSIGNED TO LIE—
Mar 5, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2008CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2008DOCKASSIGNED TO EXAMINER—
May 29, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance